J J Edwin1, F Reyes Domingo2, T F Booth3, T Mersereau2, D M Skowronski4, C Chambers4, K Simmonds5, A N Scott5, A L Winter6, A Peci6, J Gubbay6, S J Drews7, M Krajden4, T Karnauchow8, M Smieja9, S Rempel1, M Murti10, S Pollock11, R Gustafson12, D Hoyano13, S Allison14, S Fathima7, K Pabbaraju7, S Wong7, R Tellier7, G Tipples7, R R Gad15, S N Mukhi3, Y Jafari16, E Grudeski3, A McDermid3, T Wong2. 1. Centre for Public Health Infrastructure, Public Health Agency of Canada, Ottawa, ON. 2. Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON. 3. National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB. 4. British Columbia Centre for Disease Control, Vancouver, BC. 5. Alberta Health, Edmonton, AB. 6. Public Health Ontario, Toronto, ON. 7. Alberta Provincial Laboratory for Public Health, Edmonton and Calgary, AB. 8. Children's Hospital of Eastern Ontario, Ottawa, ON. 9. Hamilton Regional Laboratory Medicine Program, Hamilton, ON. 10. Fraser Health Authority, Surrey, BC. 11. Interior Health Authority, Kelowna, BC. 12. Vancouver Coastal Health Authority, Vancouver, BC. 13. Vancouver Island Health Authority, Victoria, BC. 14. Northern Health Authority, Prince George, BC. 15. New Brunswick Department of Health, Fredericton, NB. 16. Northwest Territories Health and Social Services, Yellowknife, NT.
Abstract
BACKGROUND: Enterovirus D68 (EV-D68) has been detected infrequently and has not been associated with severe disease in Canada. In the early fall of 2014, following an unusual case increase in the United States, clusters of EV-D68 among children and some adults manifesting severe symptoms were reported in Canada. OBJECTIVE: To provide an initial epidemiological summary of pediatric cases hospitalized with EV-D68 in Canada. METHODS: A time-limited surveillance pilot was conducted collecting information on pediatric cases (less than 18 years of age) hospitalized with EV-D68 between September 1 and 30, 2014. RESULTS: In total, 268 cases were reported from Ontario (n=210), Alberta (n=45), and British Columbia (n=13). Of the 268 reported cases, 64.9% (n=174) were male; the sex difference was statistically significant (p<0.01). Age was reported for 255 cases, with a mean age for males of 5.4 years and for females of 5.3 years. For cases with data available, 6.8% (18/266) were admitted to an intensive care unit. Of those where clinical illness was recorded, respiratory illness alone was present in 98.3% (227/231), neurologic illness alone was present in 0.4% (n=1), and both illnesses were present in 0.9% of cases (n=2); cases with neither respiratory nor neurologic illness were rare (n=1). Of the 90 cases with additional clinical information available, 43.3% were reported as having asthma. No deaths were reported among the 268 cases. CONCLUSION: The EV-D68 outbreak in Canada in September 2014 represents the beginning of a novel outbreak associated with severe illness in children. These findings provide the first epidemiological summary of severe cases of EV-D68 as an emergent respiratory pathogen in Canada. The continued investigation of this pathogen is necessary to build on these results and capture the full spectrum of associated illness.
BACKGROUND: Enterovirus D68 (EV-D68) has been detected infrequently and has not been associated with severe disease in Canada. In the early fall of 2014, following an unusual case increase in the United States, clusters of EV-D68 among children and some adults manifesting severe symptoms were reported in Canada. OBJECTIVE: To provide an initial epidemiological summary of pediatric cases hospitalized with EV-D68 in Canada. METHODS: A time-limited surveillance pilot was conducted collecting information on pediatric cases (less than 18 years of age) hospitalized with EV-D68 between September 1 and 30, 2014. RESULTS: In total, 268 cases were reported from Ontario (n=210), Alberta (n=45), and British Columbia (n=13). Of the 268 reported cases, 64.9% (n=174) were male; the sex difference was statistically significant (p<0.01). Age was reported for 255 cases, with a mean age for males of 5.4 years and for females of 5.3 years. For cases with data available, 6.8% (18/266) were admitted to an intensive care unit. Of those where clinical illness was recorded, respiratory illness alone was present in 98.3% (227/231), neurologic illness alone was present in 0.4% (n=1), and both illnesses were present in 0.9% of cases (n=2); cases with neither respiratory nor neurologic illness were rare (n=1). Of the 90 cases with additional clinical information available, 43.3% were reported as having asthma. No deaths were reported among the 268 cases. CONCLUSION: The EV-D68 outbreak in Canada in September 2014 represents the beginning of a novel outbreak associated with severe illness in children. These findings provide the first epidemiological summary of severe cases of EV-D68 as an emergent respiratory pathogen in Canada. The continued investigation of this pathogen is necessary to build on these results and capture the full spectrum of associated illness.
Authors: Adam Meijer; Sabine van der Sanden; Bianca E P Snijders; Giovanna Jaramillo-Gutierrez; Louis Bont; Cornelis K van der Ent; Pieter Overduin; Shireen L Jenny; Edin Jusic; Harrie G A M van der Avoort; Gavin J D Smith; Gé A Donker; Marion P G Koopmans Journal: Virology Date: 2011-12-15 Impact factor: 3.616
Authors: M Steven Oberste; Kaija Maher; David Schnurr; Mary R Flemister; Judith C Lovchik; Heather Peters; Wendy Sessions; Carol Kirk; Nando Chatterjee; Susan Fuller; J Michael Hanauer; Mark A Pallansch Journal: J Gen Virol Date: 2004-09 Impact factor: 3.891
Authors: Daniel M Pastula; Negar Aliabadi; Amber K Haynes; Kevin Messacar; Teri Schreiner; John Maloney; Samuel R Dominguez; Emily Spence Davizon; Eyal Leshem; Marc Fischer; W Allan Nix; M Steven Oberste; Jane Seward; Daniel Feikin; Lisa Miller Journal: MMWR Morb Mortal Wkly Rep Date: 2014-10-10 Impact factor: 17.586
Authors: Claire M Midgley; Mary Anne Jackson; Rangaraj Selvarangan; George Turabelidze; Emily Obringer; Daniel Johnson; B Louise Giles; Ajanta Patel; Fredrick Echols; M Steven Oberste; W Allan Nix; John T Watson; Susan I Gerber Journal: MMWR Morb Mortal Wkly Rep Date: 2014-09-12 Impact factor: 17.586